Arcus Biosciences, Inc. (RCUS) Social Stream
ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RCUS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $70 | $50 | $59.833 | $25.72 | 132.63% |
| 2021-11-17 | 8 | $70 | $48 | $58.142 | $25.72 | 126.06% |
| 2021-11-18 | 8 | $100 | $48 | $62.714 | $25.72 | 143.83% |
| 2021-11-22 | 9 | $100 | $48 | $64.857 | $25.72 | 152.17% |
| 2022-02-24 | 7 | $100.001 | $53 | $67 | $25.72 | 160.5% |
| 2022-04-12 | 7 | $100.001 | $53 | $68 | $25.72 | 164.39% |
| 2022-05-10 | 7 | $77 | $53 | $63.143 | $25.72 | 145.5% |
| 2022-05-13 | 7 | $77 | $42 | $59.571 | $25.72 | 131.61% |
| 2022-07-08 | 7 | $66 | $42 | $55.714 | $25.72 | 116.62% |
| 2022-08-04 | 7 | $60 | $36 | $50.428 | $25.72 | 96.07% |
| 2022-08-18 | 7 | $60 | $36 | $48.571 | $25.72 | 88.85% |
The Trend in the Analyst Price Target
RCUS's average price target has moved down $16.29 over the prior 38 weeks.
RCUS reports an average of 90.05% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-22 | 9 | 100.000 | 48 | 64.857 | 48.09 | 34.87% |
| 2021-11-22 | 9 | 100.000 | 53 | 67.000 | 48.09 | 39.32% |
| 2022-02-24 | 7 | 100.001 | 53 | 67.000 | 35.59 | 88.26% |
| 2022-03-29 | 7 | 100.001 | 53 | 68.000 | 37.00 | 83.78% |
| 2022-05-11 | 7 | 77.000 | 42 | 59.571 | 17.23 | 245.74% |
RCUS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
RCUS's average broker recommendation rating improved by 0.29 over the prior 29 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ARCUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1299.22% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ARCUS BIOSCIENCES INC's variance in analysts' estimates is lower than -1010.24% of them.
- RCUS has a higher average analyst price target than 1291.09% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, ARCUS BIOSCIENCES INC's number of analysts covering the stock is higher than 1079.3% of them.
Stocks similar to ARCUS BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RCKT, QURE, and PTGX.
View All Top Stocks by Price Target
Is RCUS a Buy, Hold or Sell? See the POWR Ratings now!